Table 2 Outcomes Absolute Values and Multivariate Cox regression analysis.
Underweight (BMI < 18.5) | Normal weight (BMI 18.5–25) | Overweight (BMI 25–30) | Obese (BMI > 30) | Multivariable adjusted regression analysis OR, HR or regression coefficient (95% CI) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
Underweight vs. Normal weight | Overweight vs. Normal weight | Obese vs. Normal weight | ||||||||
Primary outcome | OR/HR | P value | OR/HR | P value | OR/HR | P value | ||||
§TTCS (days) | 4.4 (3.0–6.8) | 3.4 (3.0–4.0) | 3.0 (2.6–4.0) | 4.4 (3.5–5.0) | #0.63 | 0.008 | #1.01 | 0.88 | #0.82 | 0.07 |
Secondary outcomes | ||||||||||
LOS (days) | 7.0 (7.0–11.0) | 7.0 (6.0–7.0) | 7.0 (6.0–7.0) | 7.0 (6.0–8.0) | #0.55 | <0.001 | #1.00 | 0.96 | #0.97 | 0.79 |
30-day Mortality | 4 (8.7) | 10 (3.5) | 6 (2.2) | 7 (4.1) | ¶2.19 | 0.28 | ¶0.58 | 0.35 | ¶1.41 | 0.58 |
ICU admission | 0 | 15 (5.3) | 10 (3.7) | 11 (6.5) | – | – | ¶0.72 | 0.47 | ¶1.04 | 0.93 |
ƒCAP complications | 18 (39.1) | 71 (27.3) | 80 (31.5) | 50 (31.9) | ¶1.71 | 0.13 | ¶1.19 | 0.40 | ¶1.19 | 0.46 |
Intravenous antibiotics (days) | 5.0 (3.0–8.0) | 4.0 (3.0–6.0) | 5.0 (3.0–6.5) | 4.0 (3.0–6.0) | +1.47 | 0.049 | +0.19 | 0.63 | +−0.05 | 0.91 |
Total antibiotics (days) | 10.0 (7.5–14.0) | 8.0 (7.0–11.0) | 9.0 (7.0-11.0) | 9.0 (7.0–11.0) | +2.54 | 0.003 | +−0.05 | 0.91 | +0.05 | 0.93 |
